# Nitroglycerin

## Millisrol inj 5mg/10mL

| 藥物代碼 | IMIL |
| :--- | :--- |
| 適應症 | Control of peri-op hypertension; CHF associated with acute MI. Treatment of angina pectoris unresponsive to recommended doses of organic nitrates &/or a β- blocker. Production of controlled hypotension during neurosurgical & orthopedic surgical procedures. |
| 副作用 | Tachycardia, arrhythmia, sudden drop of BP, deterioration of cardiac output, methemoglobinemia, headache, nausea, vomiting.Cardiovascular: HypotensionDermatologic: Erythroderma, Flushing, RashNeurologic: Headache \(63% \), Lightheadedness \(6% \) |
| 禁忌 | Glaucoma, severe anemia. |
| 藥物保存方式 | 避光,室溫儲存 |
| 用法用量 | Maintenance of reduced BP during surgery. 1-5 mcg/kg/min. Emergency treatment for abnormal hypertension during surgery 0.5-5 mcg/kg/min. Acute cardiac insufficiency \(including the acute exacerbation period of chronic cardiac insufficiency\) Initially 0.05-0.1 mcg/kg/min & increase drip rate to 0.1-0.2 mcg/kg/min every 5-15 mins until desired left ventricular repletion pressure is obtained. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Human data suggest low risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D5W】 可選 仿單建議  【D5NS】 可選  【N/S】 可選 仿單建議  【L/R】 可選 仿單建議 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 稀釋成0.005 ~ 0.05% \(50 ~ 500 mcg/mL\)，IV infusion rate: 0.05 - 5 mcg/kg/min依適應症不同，應使用玻璃或non-PVC材質。 |
| 注意事項 | 1. 應使用玻璃或non-PVC材質 2. 點滴速度較低及輸注管較長，皆會增加輸注時藥品被吸附的比率。 3. 使用本劑應監測血壓。 |

## Nitrostat \(NTG\) 0.6mg

| 藥物代碼 | ONTG6 |
| :--- | :--- |
| 適應症 | Treatment & prophylaxis of angina pectoris. |
| 副作用 | Headache, vertigo, weakness, palpitation & postural hypotension. Marked sensitivity to the hypotensive effects of nitrates \(manifested by nausea, vomiting, weakness, diaphoresis, pallor & collapse\). Flushing, drug rash & exfoliative dermatitis.Cardiovascular: HypotensionDermatologic: Erythroderma, Flushing, RashNeurologic: Headache \(63% \), Lightheadedness \(6% \) |
| 禁忌 | Severe anemia; raised intracranial pressure, early MI, patients taking sildenafil. |
| 藥物保存方式 | 室溫 |
| 用法用量 | 0.6 mg sublingually or buccally at 1st sign of acute attack, may be repeated every 5 mins for 3 doses. Prophylaxis, 0.6 mg 5-10 mins prior to activity which may precipitate an attack. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Human data suggest low risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | SL |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

